Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  WIENER BOERSE AG  >  Sanochemia Pharmazeutika AG    SCPH   AT0000776307

Real-time Quote. Real-time TRADEGATE AG - 12/18 08:00:19 am
1.4740 EUR   +2.36%
11/09 SANOCHEMIA PHAR : Successful Phase I Study Results
09/11 SANOCHEMIA PHAR : Tolperisone USA
07/18 SANOCHEMIA PHAR : Advantage of tolperisone in comparison to another ..
 SummaryChartsNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Wiener Boerse Ag
12/07/2017 12/11/2017 12/13/2017 12/14/2017 12/15/2017 Date
1.519 1.52 1.451 1.421 1.44 Last
6897 2500 2612 20000 14300 Volume
+1.27% +0.07% -4.54% -2.07% +1.34% Change
Financials (€)
Sales 2017 49,2 M
EBIT 2017 1,30 M
Net income 2017 -
Debt 2017 -
Yield 2017 -
Sales 2018 46,5 M
EBIT 2018 1,80 M
Net income 2018 -
Debt 2018 -
Yield 2018 -
P/E ratio 2017 -
P/E ratio 2018
Capi. / Sales2017 0,38x
Capi. / Sales2018 0,40x
Capitalization 18,5 M
More Financials
Company
SANOCHEMIA Pharmazeutika AG engages in the manufacture and distribution of pharmaceutical products.It operates through the following segments: Production, Human Pharmaceuticals, Veterinary Pharmaceuticals, and Research and Development.The Production segment focuses on synthesis of active... 
Sector
Pharmaceuticals
Calendar
01/25Earnings Release
More about the company
Latest news on SANOCHEMIA PHARMAZEUTIKA A
11/09 SANOCHEMIA PHARMAZEUTIKA : Successful Phase I Study Results
09/11 SANOCHEMIA PHARMAZEUTIKA : Tolperisone USA
07/18 SANOCHEMIA PHARMAZEUTIKA : Advantage of tolperisone in comparison to another mus..
06/06 SANOCHEMIA PHARMAZEUTIKA : Notice of Allowance for Tolperisone in the US
05/18SANOCHEMIA PHARMAZEUTIKA AG : half-yearly earnings release
03/27 SANOCHEMIA PHARMAZEUTIKA : Participation at the ECR
01/19 SANOCHEMIA PHARMAZEUTIKA : Advancement of Tolperisone's Clinical Development in ..
01/13 SANOCHEMIA PHARMAZEUTIKA : Grant of patent for Vidon® in the USA
01/06 SANOCHEMIA PHARMAZEUTIKA : "Compositions of Tolperisone" in Patent Application A..
More news
Sector news : Specialty & Advanced Pharmaceuticals
04:21p TEVA PHARMACEUTICAL INDUSTRIES : Strike over Teva Pharm job cuts briefly shuts d..
12/16 PROCTER & GAMBLE : P&G appoints Peltz to board despite losing proxy battle
12/16 NELSON PELTZ : P&G appoints Peltz to board despite losing proxy battle
12/15 JAZZ PHARMACEUTICALS : Pennsylvania man admits to trading on tips about drug com..
12/15DJSTOCKS TO WATCH : CSX, Aclaris, Alnylam, Rigel
More sector news : Specialty & Advanced Pharmaceuticals
Chart SANOCHEMIA PHARMAZEUTIKA A
Duration : Period :
Sanochemia Pharmazeutika A Technical Analysis Chart | SCPH | AT0000776307 | 4-Traders
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 2
Average target price 3,00 €
Spread / Average Target 108%
Managers
NameTitle
Eveline Frantsits Chairman-Supervisory Board
Stefan Welzig Chief Financial & Technical Officer
Christina Abrahamsberg Chief Scientific Officer
Anton Dallos Member-Supervisory Board
Werner Josef Frantsits Member-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
SANOCHEMIA PHARMAZEUTIKA AG3.67%22
ABBVIE53.78%155 345
MERCK KGAA-9.18%13 747
KYOWA HAKKO KIRIN CO LTD33.44%11 050
JAZZ PHARMACEUTICALS PLC24.28%8 125
ZHANGZHOU PIENTZEHUANG PHARMACEUTICL LTD38.39%5 638